Dietary carbohydrates raise blood glucose levels, and limiting carbohydrate intake improves
glycemia in patients with type 2 diabetes. Low carbohydrate intake (< 25 g) allows the body …

Pre-clinical and cell culture evidence supports the role of the ketone beta-hydroxybutyrate
(BHB) as an immunomodulatory molecule that may inhibit inflammatory signalling involved …

Several health-beneficial effects are associated with intake of medium-chain triacylglycerol
(MCT); however, the underlying mechanisms are unknown. Furthermore, it remains …

Ketone bodies are produced from free fatty acids by the liver when blood glucose levels are
low, such as during starvation or carbohydrate restriction. Endogenously produced ketone …

Diabetes mellitus (DM) is a metabolic disease with an increasing prevalence every year,
especially type 2 DM. Before insulin as a DM therapy, the ketogenic diet was known as the …

The potential therapeutic effects of ketosis have recently garnered attention in the scientific
community and lay public. Although typically achieved by fasting or following a restrictive …

Dietary carbohydrates raise blood glucose and limiting carbohydrate intake improves
glycemia in patients with T2D. Low carbohydrate intake (< 25 g) allows the body to utilize fat …

Summary β-Hydroxybutyrate (BHB) is an abundant ketone body. To date, all known
pathways of BHB metabolism involve the interconversion of BHB and primary energy …